technetium tc 99m sestamibi has been researched along with Substance Withdrawal Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qutbi, M | 1 |
| Biedroń, W; Gawlikowski, T; Hubalewska-Dydejczyk, A; Pach, D | 1 |
2 other study(ies) available for technetium tc 99m sestamibi and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
What is this image? 2019: Image 2 result : Reduction in interfering gastric wall uptake on myocardial perfusion SPECT following a 2-week period of omeprazole withdrawal.
Topics: Female; Heart Ventricles; Humans; Middle Aged; Myocardial Perfusion Imaging; Omeprazole; Proton Pump Inhibitors; Stomach; Substance Withdrawal Syndrome; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2019 |
[Withdrawal syndrome complicated with heart left ventricle dysfunction in young woman addicted to alcohol].
Topics: Adult; Alcoholism; Bipolar Disorder; Echocardiography; Electrocardiography; Female; Humans; Substance Withdrawal Syndrome; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2007 |